IVERIC bio, Inc. (ISEE) has an overall financial health rating of B with a composite score of 0 out of 5.
This suggests the company faces some financial challenges worth monitoring. Rating as of 2023-07-10.
| Date | Rating | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2023-07-10 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2023-07-07 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2023-07-06 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2023-07-05 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2023-07-03 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2023-06-30 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2023-06-29 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2023-06-28 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2023-06-27 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2023-06-26 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2023-06-23 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2023-06-22 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 |
